UPDATE 1-Valeant agrees to sell Paragon to settle U.S. antitrust charges

WASHINGTON, Nov 7 (Reuters) - Valeant Pharmaceuticals

, which owns Bausch & Lomb, has agreed to sell Paragon

Holdings to settle allegations that its acquisition of the

smaller company was illegal...

Read more